Rush Medical Center Home Page Information for healthcare Professionals Rush University
FIND A DOCTOR
PATIENT & VISTOR SERVICES
HEALTH INFORMATION
CLINICAL SERVICES
EVENTS & CLASSES
RUSH NEWS ROOM
CLINICAL TRIALS
RESEARCH AT RUSH
NURSING AT RUSH
WORK AT RUSH
GIVING TO RUSH

Bookmark This Page
Clinical Trails at Rush Policosonal for Dyslipidemia in HIV
Clinical Trial Protocol ID
05062103

Clinical Trial Investigator Name
Barbara Swanson

Clinical Trial Title

Policosonal for dyslipidemia in HIV



Clinical Trial Protocol Description

The purpose of this study is to evaluate the safety and efficacy of a 12-week course of sugar cane-derived policosanol in a sample of 70 persons with HIV-related dyslipidemia. Safety and efficacy outcomes will be measured at the screening visit and at 0, two, six and 12 weeks. Policosanol is a dietary supplement extracted from purified sugar cane wax. Policosanol has demonstrated tolerability and lipid-lowering properties in non-HIV-infected populations.



Clinical Trial Eligibility Criteria

You may be eligible to participate in this study if you:

  • Are HIV-infected
  • Have a CD4 count greater than 250 cells/mm3
  • Are between 18 and 60 years of age
  • Are currently taking HIV medications

This is a partial list of eligibility requirements. To inquire about your specific eligibility, please call the phone number provided.





Contact Name Barbara Swanson
Contact Phone (312) 942-8977
Contact E-mail clinical_trials@rush.edu
Promotional Information

Clinical Trials Home
Infectious Disease Trials
Policosonal for Dyslipidemia in HIV

   
Find a Doctor | Patient & Visitor Services | Health Information
Clinical Services | Events & Classes | Rush News Room | Clinical Trials
Research At Rush
Disclaimer | Privacy Statement | Site Map

© Rush University Medical Center, Chicago, Illinois